Abstract Title:

Direct enantiomer separation of thyroxine in pharmaceuticals using crown ether type chiral stationary phase.

Abstract Source:

Arch Pharm Res. 2010 Sep;33(9):1419-23. Epub 2010 Oct 14. PMID: 20945141

Abstract Author(s):

So Hee Jeon, Minhee Kim, Hyo-Kyung Han, Wonjae Lee

Article Affiliation:

College of Pharmacy, Chosun University, Gwangju, 501-759, Korea.


Thyroxine is the tyrosine based hormone produced by the thyroid gland, containing a chiral center in its molecular structure. Synthetic thyroxine is commercially available to treat thyroid dysfunctions, but only a few direct analytical methods to determine its optical purity have been reported. This study attempted to find an optimized liquid chromatographic condition for direct enantiomer separation on crown ether type chiral stationary phase. Among various mobile phases tested, 100% methanol solution containing 10 mM H(2)SO(4) was found to be most appropriate. This chromatographic method was validated and applied to measure the optical purity of six different L-thyroxine products from three domestic pharmaceutical companies and four commercially available D- and L-thyroxine reagents. The chromatographic results showed that every pharmaceutical product had quite high optical purity of above 97% (all but one were higher than 99%) while two of four thyroxine reagents demonstrated relatively higher enantiomer impurity (5-6%).

Study Type : Animal Study
Additional Links

Print Options

Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.